Biogen halts work on several drugs as it awaits FDA decisions
With multiple FDA drug approval decisions on the horizon — including one expected later today — CEO Christopher Viehbacher isn't waiting to maximize profits.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Rowan Walrath Source Type: news
More News: Health Management